A scientific team is developing a CAR T-cell gene therapy for advanced metastatic prostate cancer at the Abramson Cancer Center of the University of Pennsylvania with a $500,000 grant from Alliance for Cancer Gene Therapy.
In what appears to be a significant reorganization, Gary Reedy, CEO of the American Cancer Society, announced to the staff of the Atlanta-based charity that he will be stepping away from its day-to-day operations.
If the mortality rate for lung cancer is starting to fall of a cliff in part because of treatment effect—contributing to more than a third of the 2.2% decline in overall cancer mortality from 2016 to 2017—is that signal showing up on the radar of NCI's Surveillance, Epidemiology, and End Results (SEER) Program?
Rebecca Siegel doesn't usually pay attention to one-year drops in data trends, but the 2.2% decline in overall cancer mortality from 2016 to 2017—driven primarily by lung cancer—seemed too big to ignore.
Predictive Technology Group and Atrin Pharmaceuticals are collaborating to develop molecular diagnostic tools to improve selection of cancer patients who would most benefit from treatment with DNA Damage and Response inhibitors, including Atrin's and other small molecule ATR inhibitors.
University of California San Diego School of Medicine researchers used genetically engineered human pluripotent stem cells to create a cancer model to study in vivo how glioblastoma develops and changes over time.
Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests.
The Johns Hopkins University established a new cancer center, The Mark Foundation Center for Advanced Genomics and Imaging. The center will initially receive $5 million over two years from the Mark Foundation.
Eileen Smith was appointed chair of the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.
An $18 million commitment from the Simms/Mann Family Foundation, led by Victoria Mann Simms and Ronald Simms, will support UCLA's expansion of integrative psychosocial care for people with cancer and their families into communities throughout Southern California.
